REGN logo

REGN

Profile

Full Name

Regeneron Pharmaceuticals, Inc.

Ticker Symbol

REGN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 2, 1991

Indexes

S&P 500,NASDAQ 100

Website

http://www.regeneron.com

Employees

15158

Key Details

Price

$575.63(+9.07%)

Market cap

Last Dividend

$0.88

TTM Dividend yield

0.15%

Annual revenue

$14.20B(+8.27% YoY)

Annual EPS

$38.34(+10.27% YoY)

PE ratio

14.65

Next earnings date

Aug 1, 2025

Next ex-dividend date

May 20, 2025

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $575.63
    REGN price is $575.63

    30-Day Relative Volume

    1.45
    REGN 30-day relative volume is 1.45

    Price Performance

    Price Today change

    +9.07%
    REGN price is up +9.07% today

    Price YTD change

    -19.19%
    REGN price is down -19.19% since January 1st

    Price 1-year change

    -40.89%
    REGN price is down -40.89% year-on-year

    Price 3-year change

    -9.2%
    REGN price is down -9.2% over the past 3 years

    Price Range

    Price All-time high

    $1211.20
    REGN price is currently -52.47% below its historical high of $1211.20

    Price 3-year low

    $520.50
    REGN price is currently +10.59% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $62.15B
    REGN market capitalization is $62.15 billion

    Market cap 3-year change

    -10.76%
    REGN market capitalization is down -10.76% over the past 3 years

    Market cap All-time high

    $132.20B
    REGN market capitalization is currently -52.99% below its historical high of $132.20 billion

    Market cap sector rank

    97.72%
    REGN market capitalization is higher than 97.72% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -2.01%
    REGN shares outstanding is down -2.01% year-on-year

    Shares Outstanding 3-Year Change

    -1.71%
    REGN shares outstanding is down -1.71% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.65
    REGN beta is 0.65

    200-day SMA

    $824.33
    REGN price is currently -30.17% below its 200-day simple moving average

    50-day SMA

    $617.87
    REGN price is currently -6.84% below its 50-day simple moving average

    RSI

    47.73
    REGN 14-day relative strength index is 47.73

    Volume

    1.45
    REGN 30-day relative volume is 1.45

    ATR

    $27.44
    REGN average true range is $27.44

    10-day Historical Volatility

    81.77%
    REGN 10-day historical volatility is 81.77%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.88
    REGN last dividend was $0.88 per share, with an ex-dividend date of February 20, 2025

    Next Dividend

    $0.88
    REGN has announced a dividend of $0.88 per share, with an ex-dividend date set for May 20, 2025

    Dividend per share

    Dividend per share

    -
    REGN annual dividend per share value is unknown

    Dividend per share Sector Rank

    -
    REGN annual dividend per share is unknown

    Dividend per share 1-Year Change

    -
    REGN annual dividend per share 1-year change is unknown

    Dividend per share 3-Year Change

    -
    REGN annual dividend per share 3-year change is unknown

    Dividend yield

    Dividend yield

    -
    REGN annual dividend yield value is unknown

    Dividend yield Sector Rank

    -
    REGN annual dividend yield is unknown

    Other

    Payout ratio

    -
    REGN annual payout ratio value is unknown

    Dividends paid

    -
    REGN annual dividends paid value is unknown

    Free cash flow

    $3.54B
    REGN annual free cash flow is $3.54 billion

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $14.20B
    REGN annual revenue is $14.20 billion

    Revenue Analysts estimate

    $13.48B
    REGN annual revenue is currently +5.34% higher than the consensus analysts' forecast

    Revenue 1-year change

    +8.27%
    REGN annual revenue is up +8.27% year-on-year

    Revenue Sector rank

    95.25%
    REGN annual revenue is higher than 95.25% of companies in Healthcare sector

    EPS

    EPS

    $38.34
    REGN annual earnings per share is $38.34

    EPS Analysts estimate

    $35.79
    REGN annual earnings per share is currently +7.13% higher than the consensus analysts' forecast

    EPS 1-year change

    +10.27%
    REGN annual earnings per share is up +10.27% year-on-year

    EPS Sector rank

    99.75%
    REGN annual earnings per share is higher than 99.75% of companies in Healthcare sector

    Profit

    Gross profit

    $12.23B
    REGN annual gross profit is $12.23 billion

    Gross margin

    86.13%
    REGN annual gross profit margin is 86.13%

    Operating profit

    $4.09B
    REGN annual operating income is $4.09 billion

    Operating margin

    28.10%
    REGN annual operating profit margin is 28.10%

    Net income

    $4.41B
    REGN annual net profit is $4.41 billion

    Net margin

    31.07%
    REGN annual net profit margin is 31.07%

    Expenses

    Total expenses

    $10.11B
    REGN annual total expenses is $10.11 billion

    Operating expenses

    $8.14B
    REGN annual total operating expenses is $8.14 billion

    Cost of goods sold

    $1.97B
    REGN annual cost of goods sold is $1.97 billion

    Selling, general & administrative expenses

    $2.95B
    REGN annual SGA is $2.95 billion

    Depreciation and amortization

    $482.90M
    REGN annual depreciation & amortization is $482.90 million

    Interest expense

    $55.20M
    REGN annual interest expense is $55.20 million

    Income tax

    $367.30M
    REGN annual income tax is $367.30 million

    EBIT & EBITDA

    EBIT

    $4.84B
    REGN annual earnings before interest & taxes is $4.84 billion

    EBITDA

    $5.32B
    REGN annual EBITDA is $5.32 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $37.76B
    REGN annual total assets is $37.76 billion

    Non current assets

    $19.10B
    REGN annual long term assets is $19.10 billion

    Current assets

    $18.66B
    REGN annual total current assets is $18.66 billion

    Cash and cash equivalents

    $2.49B
    REGN annual cash & cash equivalents is $2.49 billion

    Accounts receivable

    $6.21B
    REGN annual accounts receivable is $6.21 billion

    Inventory

    $3.09B
    REGN annual inventory is $3.09 billion

    Liabilities

    Total liabilities

    $8.41B
    REGN annual total liabilities is $8.41 billion

    Long term liabilities

    $4.46B
    REGN annual total long term liabilities is $4.46 billion

    Current liabilities

    $3.94B
    REGN annual total current liabilities is $3.94 billion

    Accounts payable

    $789.50M
    REGN annual accounts payable is $789.50 million

    Debt

    Total debt

    $2.70B
    REGN annual total debt is $2.70 billion

    Total debt 1-year change

    +0.06%
    REGN annual total debt is up +0.06% year-on-year

    Long term debt

    $2.70B
    REGN annual long term debt is $2.70 billion

    Short term debt

    -
    REGN annual short term debt value is unknown

    Equity & Capital

    Shareholders equity

    $29.35B
    REGN annual stockholders equity is $29.35 billion

    Book value

    $29.35B
    REGN annual book value is $29.35 billion

    Retained earnings

    $31.67B
    REGN annual retained earnings is $31.67 billion

    Working capital

    $14.72B
    REGN annual working capital is $14.72 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $4.42B
    REGN annual cash flow from operations is $4.42 billion

    Cash from operations 1-year change

    -3.78%
    REGN annual cash flow from operations is down -3.78% year-on-year

    Cash from investing

    -$2.47B
    REGN annual cash flow from investing activities is -$2.47 billion

    Cash from investing 1-year change

    +22.51%
    REGN annual cash flow from investing activities is up +22.51% year-on-year

    Cash from financing

    -$2.20B
    REGN annual cash flow from financing activities is -$2.20 billion

    Cash from financing 1-year change

    -22.93%
    REGN annual cash flow from financing activities is down -22.93% year-on-year

    CAPEX

    CAPEX

    $881.60M
    REGN annual capital expenditures is $881.60 million

    CAPEX 1-year change

    -4.84%
    REGN annual capital expenditures is down -4.84% year-on-year

    Free Cash Flow

    Free cash flow

    $3.54B
    REGN annual free cash flow is $3.54 billion

    Free cash flow 1-year change

    -3.51%
    REGN annual free cash flow is down -3.51% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    86.13%
    REGN annual gross profit margin is 86.13%

    Operating margin

    28.10%
    REGN annual operating profit margin is 28.10%

    Net margin

    31.07%
    REGN annual net profit margin is 31.07%

    ROA & ROE

    ROA

    12.46%
    REGN annual return on assets is 12.46%

    ROE

    15.95%
    REGN annual return on equity is 15.95%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    14.65
    REGN price to earnings ratio is 14.65

    PE ratio Sector rank

    26.34%
    REGN price to earnings ratio is higher than 26.34% of companies in Healthcare sector

    PB Ratio

    PB ratio

    2.11
    REGN price to book ratio is 2.11

    PB ratio Sector rank

    62.17%
    REGN price to book ratio is higher than 62.17% of companies in Healthcare sector

    PS Ratio

    PS ratio

    4.41
    REGN price to sales ratio is 4.41

    PS ratio Sector rank

    61.57%
    REGN price to sales ratio is higher than 61.57% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $61.76B
    REGN enterprise value is $61.76 billion

    Enterprise value Sector rank

    97.62%
    REGN enterprise value is higher than 97.62% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    11.17
    REGN EV/EBITDA is 11.17

    EV/EBITDA Sector rank

    84.63%
    REGN EV/EBITDA is higher than 84.63% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.73
    REGN annual current ratio is 4.73

    Quick ratio

    3.95
    REGN annual quick ratio is 3.95

    Leverage

    Debt to equity

    0.07
    REGN annual debt to equity ratio is 0.07

    Interest coverage ratio

    87.59
    REGN annual interest coverage ratio is 87.59

    Risk & Stability

    Piotroski F-Score

    4
    REGN piotroski f-score is 4

    Altman Z-Score

    6.88
    REGN altman z-score is 6.88

    Analyst ratings

    Recent major analysts updates

    May 1, 25 Guggenheim
    Buy
    Apr 30, 25 Wells Fargo
    Overweight
    Apr 30, 25 UBS
    Neutral
    Apr 30, 25 Truist Securities
    Buy
    Apr 30, 25 RBC Capital
    Outperform
    Apr 30, 25 Goldman Sachs
    Buy
    Apr 30, 25 Baird
    Neutral
    Apr 30, 25 BMO Capital
    Outperform
    Apr 25, 25 Baird
    Neutral
    Apr 23, 25 Truist Securities
    Buy

    Institutional Ownership

    Screeners with REGN included

    US stocks
    S&P 500 companies earnings calendar
    Stocks below SMA 200
    NASDAQ 100 companies
    Most recommended stocks
    NASDAQ Dividend Calendar
    S&P 500 companies
    Stocks below analysts price target
    S&P 500 companies dividend calendar
    Healthcare sector
    • What is the ticker symbol for Regeneron Pharmaceuticals?
    • Does Regeneron Pharmaceuticals pay dividends?
    • What sector is Regeneron Pharmaceuticals in?
    • What industry is Regeneron Pharmaceuticals in?
    • What country is Regeneron Pharmaceuticals based in?
    • When did Regeneron Pharmaceuticals go public?
    • Is Regeneron Pharmaceuticals in the S&P 500?
    • Is Regeneron Pharmaceuticals in the NASDAQ 100?
    • Is Regeneron Pharmaceuticals in the Dow Jones?
    • When was Regeneron Pharmaceuticals's last earnings report?
    • When does Regeneron Pharmaceuticals report earnings?
    • Should I buy Regeneron Pharmaceuticals stock now?

    What is the ticker symbol for Regeneron Pharmaceuticals?

    The ticker symbol for Regeneron Pharmaceuticals is NASDAQ:REGN

    Does Regeneron Pharmaceuticals pay dividends?

    Yes, Regeneron Pharmaceuticals pays dividends. The last payment was $0.88, with an ex-dividend date on February 20, 2025

    What sector is Regeneron Pharmaceuticals in?

    Regeneron Pharmaceuticals is in the Healthcare sector

    What industry is Regeneron Pharmaceuticals in?

    Regeneron Pharmaceuticals is in the Biotechnology industry

    What country is Regeneron Pharmaceuticals based in?

    Regeneron Pharmaceuticals is headquartered in United States

    When did Regeneron Pharmaceuticals go public?

    Regeneron Pharmaceuticals's initial public offering (IPO) was on April 2, 1991

    Is Regeneron Pharmaceuticals in the S&P 500?

    Yes, Regeneron Pharmaceuticals is included in the S&P 500 index

    Is Regeneron Pharmaceuticals in the NASDAQ 100?

    Yes, Regeneron Pharmaceuticals is included in the NASDAQ 100 index

    Is Regeneron Pharmaceuticals in the Dow Jones?

    No, Regeneron Pharmaceuticals is not included in the Dow Jones index

    When was Regeneron Pharmaceuticals's last earnings report?

    Regeneron Pharmaceuticals's most recent earnings report was on Apr 29, 2025

    When does Regeneron Pharmaceuticals report earnings?

    The next expected earnings date for Regeneron Pharmaceuticals is Aug 1, 2025

    Should I buy Regeneron Pharmaceuticals stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page